Jamie started at NIH as a Presidential Management Fellow (PMF) – (STEM track) Public Health Analyst, serving as the Special Assistant to the Director of ORWH. Prior to working for NIH, she was a Laboratory Analyst that developed methodologies for the destruction of chemical weapons at the Blue Grass Chemical Agent Destruction Pilot program and a Research Chemist at the Center for Disease Control and Prevention (CDC). She has expertise in multiple disciplines, including global women’s health innovation, sex, gender, and intersectionality, instrumentational analysis, analytical chemistry, behavioral neuroendocrinology, bioethics, and policy, among a few others. She has published in several peer-reviewed journals. Recently, she served as the co-chair of the Innovation Equity Forum that was responsible for the development of the Women’s Health Innovation Opportunity Map 2023. Also in 2023, Jamie was named one of the 200 Trailblazing Leaders in Women’s Health and FemTech, received a First in Femtech Award, and her third NIH Director’s Award.
Currently, she is on the Advisory Board of the Women’s Health Innovation Series, active member of the MedTech Color Community Collaborative and serves on the XPrize Global Visioneering Brain Trust. Lastly, she took part in the American Association for the Advancement of Science (AAAS) Leadership Seminar in Science & Technology Policy, attained her graduate degree in neuroscience at Tulane University and is a proud alumna of Spelman College and the Gates Millennium Scholars Program.